Filter
538
Filtered Results: 538
Text search:
TB
comorbidities
Featured
Recommendations
71
New Publications
129
Language
Document type
No document type
305
Guidelines
100
Studies & Reports
80
Strategic & Response Plan
20
Manuals
14
Training Material
7
Fact sheets
5
Infographics
4
Situation Updates
2
Resource Platforms
1
Countries / Regions
India
23
South Africa
22
Kenya
21
Western and Central Europe
17
Global
17
Africa
15
Latin America and the Carribbean
13
Ethiopia
12
Uganda
10
Ghana
9
Tanzania
9
Rwanda
9
Namibia
8
Eastern Europe
8
Senegal
7
Congo, Democratic Republic of
7
Zambia
7
Nepal
6
Bangladesh
6
Brazil
6
South–East Asia Region
6
Asia
6
Nigeria
5
Ukraine
5
Sierra Leone
4
Malawi
4
Eswatini/ Swaziland
4
Myanmar / Burma
4
Burkina Faso
3
Zimbabwe
3
Cambodia
3
Lesotho
3
Russia
3
Georgia
3
Liberia
2
Philippines
2
Germany
2
Argentina
2
Peru
2
Colombia
2
Botswana
2
East and Southern Africa
2
West and Central Africa
2
Western Pacific Region
2
Laos
2
Tajikistan
2
Romania
2
Vietnam
2
Guinea
1
Mali
1
Côte d’Ivoire / Ivory Coast
1
Cameroon
1
Somalia
1
South Sudan
1
Syria
1
Thailand
1
Central African Republic
1
North Macedonia
1
Burundi
1
Bolivia
1
Chile
1
Middle East and North Africa
1
Paraguay
1
Venezuela
1
Timor Leste/ East Timor
1
Estonia
1
Gabon
1
Authors & Publishers
Publication Years
Category
Countries
206
Clinical Guidelines
80
Public Health
21
Capacity Building
3
Women & Child Health
2
Key Resources
2
Pharmacy & Technologies
1
Toolboxes
TB
158
HIV
105
COVID-19
45
Mental Health
14
AMR
13
NCDs
13
Refugee
8
NTDs
5
Ebola
4
Conflict
4
Pharmacy
4
Health Financing Toolbox
4
Polio
3
Rapid Response
3
Caregiver
3
Disability
2
Cholera
1
The African Region has been experiencing unprecedented health challenges due to the Coronavirus disease 2019 (COVID-19) pandemic, which have compounded the already difficult task the Region was facing in moving towards universal health coverage (UHC) attainment.
The objective of Health in the Americas: Overview of the Region of the Americas in the Context of the COVID-19 Pandemic is to respond to the need to address important public health issues in an increasingly timely manner, while serving as a platform with a close focus on specific issues of regional ...
These guidelines provide updated evidence-based recommendations on the priority HCV-related topics from the 2018 WHO Guidelines for the care and treatment of persons diagnosed with chronic hepatitis C infection and the 2017 WHO Guidelines on hepatitis B and C testing. These priority areas are:
...
Antimicrobial resistance (AMR) is a threat to global health and development and it contributes to millions of deaths worldwide each year. Inappropriate use and overuse of antibiotics are driving an increase in AMR and have a detrimental impact on the effectiveness of these critical medicines. Throug...
The World Health Organization's fourth Country Cooperation Strategy 2022-2026 is an outcome of a consultative process with inputs from the Ministry of Health, various agencies in the health sector, and other relevant stakeholders. It has been developed to provide strategic direction and support towa...
Download (7.4 MB)
Overview
Epilepsy is one of the most common neurological disorders globally. The WHO epilepsy technical brief aims to strengthen action for epilepsy and complements the Intersectoral global action plan on epilepsy and other neurological disorders 2022–2031.
The technical bri...
This document focuses on the management of patients affected by gambiense HAT and
constitutes an update to the WHO therapeutic guidance issued in 2013. The main changes in recommendations concern the criteria and methods for deciding the treatment among the new set of therapeutic options and the pa...
As of 12 December 2022, over 645 million people worldwide have been diagnosed with COVID-19, with over 6.6 million deaths (4).
The Omicron variant, which emerged in late November 2021, and its subvariants, are now the dominant circulating viruses, contributing to the ongoing surge in several countr...
The WHO continuously reviews available data on SARS-CoV-2 variants of concern. For this version, the global epidemiological
situation of the COVID-19 pandemic as of 21 January 2022 – at a time when the Omicron VOC had been identified in 171
countries across all six WHO Regions and was rapidly re...
This report presents findings from research conducted by Economist Impact to assess the health, demographic, social and economic impacts associated with different scenarios for financing the HIV epidemic across 13 selected countries in Sub-Saharan Africa. The sponsorship of UNAIDS towards this repor...
The 2030 health-related Sustainable Development Goals call on countries to end AIDS as a public health threat and also to achieve universal health coverage. The World Health Organization (WHO) promotes primary health care (PHC) as the key mechanism for achieving universal health coverage, and the PH...
The Mapping Antimicrobial Resistance and Antimicrobial Use Partnership (MAAP) project has conducted a multi-year, multi-country study that provides stark insights on the under-reported depth of the antimicrobial resistance (AMR) crisis across Africa and lays out urgent policy recommendations to addr...
The Mapping Antimicrobial Resistance and Antimicrobial Use Partnership (MAAP) project has conducted a multi-year, multi-country study that provides stark insights on the under-reported depth of the antimicrobial resistance (AMR) crisis across Africa and lays out urgent policy recommendations to addr...
The Mapping Antimicrobial Resistance and Antimicrobial Use Partnership (MAAP) project has conducted a multi-year, multi-country study that provides stark insights on the under-reported depth of the antimicrobial resistance (AMR) crisis across Africa and lays out urgent policy recommendations to addr...
The Mapping Antimicrobial Resistance and Antimicrobial Use Partnership (MAAP) project has conducted a multi-year, multi-country study that provides stark insights on the under-reported depth of the antimicrobial resistance (AMR) crisis across Africa and lays out urgent policy recommendations to addr...
The Mapping Antimicrobial Resistance and Antimicrobial Use Partnership (MAAP) project has conducted a multi-year, multi-country study that provides stark insights on the under-reported depth of the antimicrobial resistance (AMR) crisis across Africa and lays out urgent policy recommendations to addr...
The WHO COVID-19 Clinical management: living guidance contains the most up-to-date recommendations for the clinical management of people with COVID-19. Providing guidance that is comprehensive and holistic for the optimal care of COVID-19 patients throughout their entire illness is important.
This document lays out economic arguments for investing in the Access to COVID-19 Tools Accelerator (ACT-Accelerator). Framed within an overall context that recognizes the broader human health and societal impacts of the COVID-19 crisis, ACT-Accelerator's Economic Investment Case argues that investm...
Cardiovascular diseases (CVDs) are a growing public health problem in Ghana and other African countries. Strokes and other CVDs have become a leading cause of death due to increasing risk factors such as hypertension. According to the Global Burden of Disease study (GBD), ischaemic heart disease was...
sthma prevalence is increasing worldwide, and surveys indicate that most patients in developed and developing countries, including South Africa, do not receive optimal care and are therefore not well controlled. Standard management guidelines adapted to in-country realities are important to support ...
